🇺🇸 FDA
Patent

US 7560118

Attenuated dengue virus comprising mutations in the NS3 gene

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 7560118 (Attenuated dengue virus comprising mutations in the NS3 gene) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/5256, A61K2039/54